Nanjing Orui Pharmaceutical

About:

Nanjing Orui Pharmaceutical focuses on research and development of antiviral drugs with unique ideas.

Website: http://aubrak.com/

Top Investors: Ruihe Capital, Tongde Capital, Ennovation Ventures, Yuandong Biological Investment Management

Description:

Total Funding Amount:

100M CNY

Headquarters Location:

Jiangbei, Chongqing, China

Founded Date:

2021-12-01

Contact Email:

aubrak(AT)aubrak.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2022-03-27

IPO Status:

Private

Industries: